Mesoblast (MEOBF) Cash & Equivalents Growth (5y) (2019 - 2026)
Powered by 
Analysis
Mesoblast (MEOBF) Cash & Equivalents Growth (5y) (2019 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Krystal Biotech | 10.27 Bn | 9.43 Bn | 112.79 Mn |
| 2 | CRISPR Therapeutics AG | 5.17 Bn | 5.17 Bn | - |
| 3 | Iovance Biotherapeutics | 3.79 Bn | 3.49 Bn | 55.72 Mn |
| 4 | Legend Biotech | 3.68 Bn | 2.71 Bn | 251.50 Mn |
| 5 | uniQure | 3.05 Bn | 3.05 Bn | 5.49 Mn |
| 6 | Beam Therapeutics | 2.65 Bn | 2.65 Bn | - |
| 7 | Precigen | 2.44 Bn | 2.44 Bn | 52.17 Mn |
| 8 | Sarepta Therapeutics | 2.33 Bn | 1.53 Bn | 251.87 Mn |
| 9 | Vericel | 1.99 Bn | 1.83 Bn | 56.40 Mn |
| 10 | Mesoblast | 246.02 Mn | 143.11 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -5.54% |
| Dec 31, 2025 | 10.89% |
| Jun 30, 2025 | 4.55% |
| Dec 31, 2024 | -14.11% |
| Jun 30, 2024 | 4.54% |
| Dec 31, 2023 | 0.14% |
| Jun 30, 2023 | 13.56% |
| Mar 31, 2023 | -3.90% |
| Dec 31, 2022 | 7.37% |
| Sep 30, 2022 | 6.32% |
| Jun 30, 2022 | 5.72% |
| Mar 31, 2022 | 2.12% |
| Dec 31, 2021 | 22.85% |
| Sep 30, 2021 | 13.95% |
| Jun 30, 2021 | 11.08% |
| Mar 31, 2021 | 9.63% |
| Dec 31, 2020 | -8.49% |
| Sep 30, 2020 | 6.81% |
| Jun 30, 2020 | 3.16% |
| Jun 30, 2019 | -22.89% |